Health Canada has granted approval for the use of a new vaccine designed to combat the respiratory syncytial virus (RSV), focusing on safeguarding two particularly vulnerable demographics: newborns, who would ...
The department of the Government of Canada responsible for national health policy, Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults aged 60 and over. ...
Final data from a late-stage study published in the New England Journal of Medicine has revealed that Pfizer’s RSV vaccine, RSVpreF, was discovered to be 82% effective in preventing severe ...
© 2026 Nigerian Canadian Newspaper Canada. Powered by NASCI.
